Guselkumab in the IL-23 inhibition landscape for ulcerative colitis. Gros B, Targownik LE. Lancet 2024 Dec 17:S0140-6736(24)02262-1. doi: 10.1016/S0140-6736(24)02262.

Read + Share

Amedeo Smart

Independent Medical Education

Gros B, Targownik LE. Guselkumab in the IL-23 inhibition landscape for ulcerative colitis. Lancet 2024 Dec 17:S0140-6736(24)02262-1. doi: 10.1016/S0140-6736(24)02262.
PMID: 39706208